Automated Breast Ultrasound Systems Market to surpass US$ 1,591.7 Million by 2024 - Coherent Market Insights

Published On : Dec 27, 2016

The Global Automated Breast Ultrasound Systems Market was valued at US$ 236.5 million in 2015, according to a new report by published by Coherent Market Insights. Increasing incidence of breast cancer is propelling market growth for automated breast ultrasound systems worldwide.

Regulatory approval from the U.S. Food & Drug Administration (FDA) for using automated breast ultrasound systems (ABUS) as an adjunct with mammography in screening women with dense breasts has augmented market growth. ABUS with better sensitivity enables screening of small tumors in women with dense breasts. Furthermore, use of ABUS in preoperative evaluation is projected to be one of the major driving factors for these systems. Providers need to focus on reducing costs, while rate of false positives can be significantly reduced through proper training of device operators. GE Healthcare offers FDA-required onsite training to technologists and radiologists for using the ABUS system. Other market players also need to practice customer engagement activities and provide additional services to their customers in order to sustain the market competition.

To know the latest trends and insights prevalent in this market, click the link below:

Advancements in automated breast ultrasound systems (ABUS) has propelled demand for handheld ultrasound system (HHUS), which is expected to drive market growth over the forecast period. Recent past has witnessed high demand for ABUS from physician to improve efficiency of diagnosis, owing to various features offered by ABUS such as high quality 3D images, reduced screening time, and the ability to screen dense breast tissues and small tumors effectively.

In 2014, the U.S. Food and Drug Administration (FDA) approved GE’s Invenia ABUS for using it as a supplementary product with mammogram in breast cancer diagnosis, which has increased the adoption of ABUS among hospitals for screening of breasts cancer. Furthermore, high prevalence of breast cancer is a major factor driving growth of the market. According to the American Cancer Society, in 2016, an estimated 246,660 new cases of invasive breast cancer were reported in the U.S. As per the estimates of the Philippine Obstetrical and Gynecological Society, the highest incidence of breast cancers were reported in Philippines, with a mammoth increase of 589% in breast cancer cases reported over a period of 30-years (1980 - 2010).

Furthermore, high adoption of ABUS is accelerating preoperative evaluation of tumors. Various studies are being conducted to establish the benefits of using ABUS in preoperative application. In January 2016, a trial was conducted by the University of Zurich for preoperative evaluation of breast cancer using ABUS in women newly diagnosed with breast cancer. Favorable outcomes of such studies are expected to further expand the scope for ABUS in preoperative evaluation, which in turn is expected to drive growth of the market.

ABUS is majorly adopted in developed economies such as the U.S., Australia, Japan, the U.K., and Canada. However, high costs of installing ABUS and low number of women opting for early breast screening is restraining growth of the market in emerging economies.

Key takeaways of the market are:

  • A major application of ABUS is in screening of patients. Increasing awareness about the consequences of delayed detection of breast cancer is encouraging patients to undergo screen test.
  • Prone type ABUS is expected to dominate the market throughout the forecast period.
  • Asia Pacific dominated the global automated breast ultrasound systems market with a revenue share of around 40% in 2015. Asia Pacific is expected to witness over 20X higher unit sales than Latin America between 2015 and 2024. This is attributed mainly to higher adoption rate of ABUS in China and Japan.
  • Growth in North America and Europe is primarily driven by high prevalence of breast cancer and increasing demand for breast screening at early stage to circumvent consequences of delayed or late-stage detection.
  • Increasing concerns regarding breast cancer has triggered government and non-profit organizations to increase awareness about the consequences and promote early detection methods of the disease. Some of these initiatives include, The Pink Initiative organization in India, Breast Cancer Initiative East Africa Inc., and Pink Ribbon Breakfast initiative by the Cancer Australia.
  • The automated breast ultrasound systems market is at the verge of consolidation. Following are the instances of the same:
    • In 2015, iVu Imaging Corp announced an alliance with Hitachi Aloka Medical, Ltd. for distribution of its automated whole breast ultrasound scanner. This was aimed at strengthening Hitachi’s presence in North America.
    • In 2014, Koninklijke Philips N.V. entered into an agreement with SonoCiné Inc. to add the latter’s automated whole breast ultrasound imaging to its ultrasound systems portfolio
  • GE and Siemens hold major share of the global market, while SonoCine and other players are emphasizing on product sales at regional level

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave,
Seattle, WA 98154
Tel: +1-206-701-6702
Email: [email protected]

"How Can I Help You" ?

Finding it difficult to find the research that would cater to your business demands? Give us a chance to help you. One of our Research Consultants will connect to provide a customized solution.

Coherent Market Insights Benefits

  • Custom Research Solution

    Talk to our research consultant to design an exclusive report as per your research needs.

  • Customer Fulfilment

    We aim to fulfil client's research demands with tailored research solutions.

  • Quick Turnaround Time Reports

    We aim to provide research studies in quickest turnaround time and in a much cost effective manner.

  • 360-degree Approach

    We cover each industry from supply and demand side with an aim to provide a most holistic research study.

  • Assured Quality

    We strive to provide most accurate and reliable research findings in our research reports.